Skip to main content
Kiran Patel, MD, Radiology, Oceanside, CA

Kiran Roshan Patel MD


Physician

Join to View Full Profile
  • 3156 Vista WaySuite 100Oceanside, CA 92056

  • Phone+1 760-547-8000

  • Fax+1 760-547-8001

Are you Dr. Patel?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Kiran Patel, MD is a board certified radiologist in Oceanside, California. He is currently licensed to practice medicine in California, New Mexico, and Maryland.

Education & Training

  • Mount Auburn Hospital
    Mount Auburn HospitalResidency, Radiology-Diagnostic, 2004 - 2008
  • West Suburban Medical Center
    West Suburban Medical CenterInternship, Transitional Year, 2003 - 2004
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2026
  • NM State Medical License
    NM State Medical License 2017 - 2023
  • MD State Medical License
    MD State Medical License 2008 - 2009
  • IL State Medical License
    IL State Medical License 2003 - 2004
  • Diagnostic Radiology
    American Board of Radiology Diagnostic Radiology

Publications & Presentations

PubMed

Press Mentions

  • Morphogenesis, with a Potential Game-Changer for Skin Cancer, Raises $2.7 Million
    Morphogenesis, with a Potential Game-Changer for Skin Cancer, Raises $2.7 MillionDecember 18th, 2020
  • Results from Phase 2 THOR-2 Study Showed Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations Treated with Erdafitinib Versus Chemotherapy
    Results from Phase 2 THOR-2 Study Showed Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations Treated with Erdafitinib Versus ChemotherapyOctober 25th, 2023